NCT06950112

Brief Summary

this study to compare the ventilation in obese patients either using Driving pressure ventilation technique or conventional protective lung strategy all by using Lung ultrasound score

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Dec 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Dec 2024Nov 2026

Study Start

First participant enrolled

December 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 23, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 29, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Expected
Last Updated

April 29, 2025

Status Verified

April 1, 2025

Enrollment Period

1 year

First QC Date

March 23, 2025

Last Update Submit

April 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The change in lung ultrasound score

    The primary outcome will be the change in Lung Ultra Sound Score between 0 and 3 (0 = normal A lines, 1 = multiple separated B lines, 2 = coalescing B lines or light beam, 3 = consolidation) from the base line.

    Periprocedural

Secondary Outcomes (9)

  • Lung compliance

    Periprocedural

  • Hemodynamic parameter as oxygen saturation

    Periprocedural

  • Hemodynamic parameter as Heart rate

    Periprocedural

  • Hemodynamic parameter as Mean arterial blood pressure

    Periprocedural

  • End-tidal carbon dioxide (ETCO2)

    Periprocedural

  • +4 more secondary outcomes

Study Arms (3)

Group D (Driving pressure)

EXPERIMENTAL

Patients will be ventilated with driving pressure-guided ventilation with VT 6-8 ml /kg of predicted body weight, and after recruitment, we will return to the baseline PEEP 5 cmH2O that will be increased by 2 cmH2O until reaching the lowest possible driving pressure for every patient. Each PEEP level will be maintained for ten respiratory cycles and DP will be calculated at the last cycle.

Device: lung ultrasound

Group L (Lung protective strategy)

EXPERIMENTAL

Patients will be ventilated with protective lung strategy with VT 6-8 ml /kg of predicted body weight, after recruitment we will return to PEEP of 8-10 cm H2O that will be maintained until the end of surgery.

Device: lung ultrasound

Group P (Physiological PEEP)

EXPERIMENTAL

Patients will be ventilated with VT 6-8 ml /kg of predicted body weight, after recruitment we will return to physiological PEEP of 5 cm H2O that will be maintained until the end of surgery.

Device: lung ultrasound

Interventions

The lung ultrasound score between 0 and 3 (0 = normal A lines, 1 = multiple separated B lines, 2 = coalescing B lines or light beam, 3 = consolidation). The aeration score will be built by the sum of the scores of the 12 segments, with a minimum of 0 and a maximum of 36 according to the aeration loss.

Group D (Driving pressure)Group L (Lung protective strategy)Group P (Physiological PEEP)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients who have a BMI 30-40 kg/m2
  • American Society of Anesthesiologists (ASA) physical status II or III
  • patients aged between 18 and 60 years,
  • patients scheduled to undergo laparoscopic bariatric surgeries.

You may not qualify if:

  • patients' refusal to participate in the study,
  • previous history of thoracic surgery,
  • Patients with a history of chest disease (COPD, emphysema, or pneumothorax),
  • Patients with abnormal pre-operative chest radiographs, such as pneumonia and pleural effusion,
  • Patients with right-side heart failure or impending failure,
  • Patients with known hypovolemia, and Patients with increased intracranial pressure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta university

Tanta, El Gharbia, 31527, Egypt

RECRUITING

Central Study Contacts

Mahmoud Gamal Arakeeb, Assistant Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant lecturer of anesthesia faculity of medicine tanta university

Study Record Dates

First Submitted

March 23, 2025

First Posted

April 29, 2025

Study Start

December 1, 2024

Primary Completion

December 1, 2025

Study Completion (Estimated)

November 1, 2026

Last Updated

April 29, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year
Access Criteria
The data will be available upon a reasonable request from the corresponding author

Locations